Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125322141 | 12532214 | 1 | I | 20160624 | 20160706 | 20160706 | EXP | GB-MHRA-EYC 00141281 | GB-MYLANLABS-2016M1026799 | MYLAN | 0.00 | Y | 0.00000 | 20160706 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125322141 | 12532214 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | UNK | Y | U | 65195 | ||||||||
| 125322141 | 12532214 | 2 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK | Y | U | 0 | ||||||||
| 125322141 | 12532214 | 3 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | UNK | Y | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125322141 | 12532214 | LT |
| 125322141 | 12532214 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125322141 | 12532214 | Hypoglycaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125322141 | 12532214 | 1 | 20160528 | 20160531 | 0 | |
| 125322141 | 12532214 | 2 | 20160528 | 20160531 | 0 | |
| 125322141 | 12532214 | 3 | 20160528 | 20160531 | 0 |